2023
DOI: 10.3390/ijms24119482
|View full text |Cite
|
Sign up to set email alerts
|

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies

Abstract: Depression and schizophrenia are two highly prevalent and severely debilitating neuropsychiatric disorders. Both conventional antidepressant and antipsychotic pharmacotherapies are often inefficient clinically, causing multiple side effects and serious patient compliance problems. Collectively, this calls for the development of novel drug targets for treating depressed and schizophrenic patients. Here, we discuss recent translational advances, research tools and approaches, aiming to facilitate innovative drug… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
references
References 248 publications
(300 reference statements)
0
0
0
Order By: Relevance